Intellectia LogoIntellectia
Product
Resources
Markets
News
Partner Program
Pricing
Log inTry for Free
Intellectia Logo
Log in
Intellectia Logo

Product

Features
Financial AI Agent
Stock Technical Analysis
Stock Monitor
Hedge Fund Tracker
AI Screener
Trading Strategies
AI Stock Picker
Swing Trading
Quant AI
Stock Chart Patterns
Daytrading Center
AI Earnings Prediction
Whales Auto Tracker
Backtesting Playground

Resources

Learn
Blog
Earnings
Tutorial
Help Center
Company
About Us
Contact
Press
Reward Program
Partner Program
Tools
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Compare
TradingView
SeekingAlpha

Markets

Trending Stocks
Hot Crypto
Trending News
All Stocks

News

Trading News
Overview
Top News
Daily Market Brief
Earnings
Latest
Newswire
Stock News
Crypto News
Monitor News
Partner ProgramPricing
Start for Free
  1. Home
    2. >
  2. Stock
    3. >
  3. APM
stocks logo

APM

-
collectAdd to Watchlistadvanced chartAdvanced Chart
$
0.000
0(0.000%)1D
collectadvanced chart
    Overview
    Forecast
    Valuation
    Earnings
High
--
Open
--
VWAP
--
Vol
--
Mkt Cap
--
Low
--
Amount
--
EV/EBITDA(TTM)
--
Total Shares
--
EV
--
EV/OCF(TTM)
--
P/S(TTM)
--
Financial AI Agent
Financial AI Agent

Valuation Metrics

The current forward P/E ratio for Aptorum Group Ltd (APM.O) is 0.02, compared to its 5-year average forward P/E of -1.36. For a more detailed relative valuation and DCF analysis to assess Aptorum Group Ltd 's fair value, click here.
  • Forward PE
  • Forward EV/EBITDA
  • Forward PS

Forward PE

The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average PE
-1.36
Current PE
0.02
Overvalued PE
0.21
Undervalued PE
-2.93

Forward EV/EBITDA

The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average EV/EBITDA
-3.67
Current EV/EBITDA
0.00
Overvalued EV/EBITDA
6.74
Undervalued EV/EBITDA
-14.08

Forward PS

The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average PS
18.94
Current PS
0.00
Overvalued PS
48.35
Undervalued PS
-10.46
Intellectia AI SwingMax
Intellectia AI SwingMax

Financials

Annual
Quarterly

Trading Trends

  • Insider
  • Hedge Fund
  • Congress Trading
Insider
Insiders are Neutral. There are no significant trading trends over the last month.
Sold
Bought
Hedge Fund
Hedge Funds are Neutral. There are no significant trading trends over the last quarter.
Sold
Bought
Congress Trading
Congress are Neutral. There are no significant trading trends over the last month.
Sold
Bought
Insider
Insiders are Neutral. There are no significant trading trends over the last month.
Sold
Bought
AI Stock Picker
AI Stock Picker

APM News & Events

Events Timeline

(ET)
2025-11-17
16:33:33
Aptorum Group seeks approval to sell 2.06 million Class A ordinary shares on behalf of shareholders.
select
2025-10-10 (ET)
2025-10-10
09:55:44
Aptorum Group reveals registered direct offering of up to $6 million
select
2025-10-09 (ET)
2025-10-09
08:57:59
Aptorum Group names Laura Philips as a new board member.
select
Sign Up For More Events
Sign Up For More Events

News

[object Object]
Preview
8.5
10-09Newsfilter
Aptorum Group to Enhance Board and Management Team with Experienced Executives Amid DiamiR Biosciences Merger Plans

  • New Board Appointment: Aptorum Group Limited has appointed Dr. Laura A. Philips as an independent director following its merger with DiamiR Biosciences Corp, bringing extensive experience in life sciences and technology development.

  • Merger Details: The all-stock merger between Aptorum and DiamiR is expected to close in the fourth quarter of 2025, subject to shareholder approval, with key personnel from DiamiR joining the combined company's board and executive team.

[object Object]
Preview
4.5
08-22Benzinga
Dow Rises More Than 300 Points; BJ's Wholesale Stock Declines Following Q2 Earnings Report

  • U.S. Stock Market Performance: U.S. stocks rose this morning, with the Dow Jones increasing by over 300 points, closing at 45,109.99, while NASDAQ and S&P 500 also saw gains.

  • Sector Movements: Communication services shares increased by 0.9%, and information technology stocks rose by 0.2% on Friday.

  • Company Earnings Reports: BJ's Wholesale Club shares fell 7% after missing revenue expectations despite beating earnings per share estimates; meanwhile, EpicQuest Education Group's shares surged 176% due to strong financial results.

  • Global Market Trends: European shares were up, with the eurozone's STOXX 600 gaining 0.4%, while Asian markets closed mixed, with Japan's Nikkei slightly up and India's BSE Sensex down 0.85%.

[object Object]
Preview
9.5
08-22Benzinga
EpicQuest Education Shares Surge Over 81%; Check Out 20 Stocks Making Moves in Premarket Trading

  • EpicQuest Education Group Performance: EpicQuest Education Group International Ltd (EEIQ) saw a significant rise in shares, climbing 81.5% to $0.98 after reporting first-half fiscal results with revenues of $5.37 million, a 29.1% increase from the previous year.

  • Other Notable Gainers: Several other stocks experienced notable pre-market gains, including Cycurion Inc (CYCU) up 66.8%, Azitra Inc (AZTR) up 44%, and Educational Development Corp (EDUC) up 16.3%.

  • Stocks Declining in Pre-Market: Conversely, Aptorum Group Limited (APM) fell 38.1%, Aethlon Medical, Inc. (AEMD) dropped 17.8%, and OceanPal Inc. (OP) declined 16.3% in pre-market trading.

  • Market Overview: The overall market showed mixed results with various companies experiencing fluctuations in stock prices following recent announcements and earnings reports.

Sign Up For More News

People Also Watch

FAQ

arrow icon

What is Aptorum Group Ltd (APM) stock price today?

The current price of APM is 1.4 USD — it has increased 2.19 % in the last trading day.

arrow icon

What is Aptorum Group Ltd (APM)'s business?

Aptorum Group Limited is a United Kingdom-based clinical-stage biopharmaceutical company dedicated to the discovery, development and commercialization of therapeutic assets to treat diseases with unmet medical needs, particularly in oncology (including orphan oncology indications) and infectious diseases. Its lead projects are ALS-4, SACT-1 and PathsDx Test. ALS-4 is a small drug molecule which appears to target the products produced by bacterial genes that facilitate the successful colonization and survival of the bacterium in the body or that cause damage to the body's systems. SACT-1 is the first repurposed drug candidate to be developed under the Smart-ACT drug discovery platform. The Company's pipeline is also enriched through the co-development of PathsDx Test, a molecular-based rapid pathogen identification and detection diagnostics technology, with Accelerate Technologies Pte Ltd, the commercialization arm of the Singapore's Agency for Science, Technology and Research.

arrow icon

What is the price predicton of APM Stock?

Wall Street analysts forecast APM stock price to fall over the next 12 months. According to Wall Street analysts, the average 1-year price target for APM is  USD with a low forecast of USD and a high forecast of USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

arrow icon

What is Aptorum Group Ltd (APM)'s revenue for the last quarter?

Aptorum Group Ltd revenue for the last quarter amounts to NaN USD, decreased % YoY.

arrow icon

What is Aptorum Group Ltd (APM)'s earnings per share (EPS) for the last quarter?

Aptorum Group Ltd. EPS for the last quarter amounts to USD, decreased % YoY.

arrow icon

What changes have occurred in the market's expectations for Aptorum Group Ltd (APM)'s fundamentals?

The market is revising No Change the revenue expectations for APM for , with the revenue forecasts being adjusted by % over the past three months. During the same period, the stock price has changed by -24.32%.
arrow icon

How many employees does Aptorum Group Ltd (APM). have?

Aptorum Group Ltd (APM) has 1 emplpoyees as of December 05 2025.

arrow icon

What is Aptorum Group Ltd (APM) market cap?

Today APM has the market capitalization of 11.40M USD.

Intellectia LogoIntellectiaIntellectia LogoIntellectia

Redefine Your Investment Decisions

TwitterTwitterYoutubeYoutubeQuoraQuoraDiscordDiscordLinkedinLinkedinTelegramTelegram
AppStoreGooglePlay

Copyright © 2025 Intellectia.AI. All Rights Reserved.

pci certified logo
Company
HomeContactAbout UsNews Release
Compare
TradingViewSeeking Alpha
Features
Financial AI AgentStock Technical AnalysisStock MonitorHedge Fund TrackerAI ScreenerDaytrading Center
Strategies
AI Stock PickerSwing TradingStock Chart PatternsEarnings TradingDaytrading CenterAI Earnings PredictionQuant AIWhales Auto TrackerBacktesting Playground
Free Tools
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Resource
BlogTutorialEarningsTrending StocksCrypto MarketPartner ProgramTerms of UsePrivacy PolicySecuritySitemap
Start for Free